APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,102 | -99.9% | 21,309 | 0.0% | 0.30% | -30.6% |
| Q3 2022 | $1,455,000 | +50.9% | 21,309 | 0.0% | 0.42% | +58.0% |
| Q2 2022 | $964,000 | -11.0% | 21,309 | 0.0% | 0.27% | +7.2% |
| Q1 2022 | $1,083,000 | +7.5% | 21,309 | 0.0% | 0.25% | +14.6% |
| Q4 2021 | $1,007,000 | +43.4% | 21,309 | 0.0% | 0.22% | +30.4% |
| Q3 2021 | $702,000 | -47.9% | 21,309 | 0.0% | 0.17% | -46.8% |
| Q2 2021 | $1,347,000 | +47.4% | 21,309 | 0.0% | 0.32% | +37.4% |
| Q1 2021 | $914,000 | -25.0% | 21,309 | 0.0% | 0.23% | -32.0% |
| Q4 2020 | $1,219,000 | +89.6% | 21,309 | 0.0% | 0.34% | +69.8% |
| Q3 2020 | $643,000 | -7.6% | 21,309 | 0.0% | 0.20% | -13.9% |
| Q2 2020 | $696,000 | +21.9% | 21,309 | 0.0% | 0.23% | -1.7% |
| Q1 2020 | $571,000 | -12.4% | 21,309 | 0.0% | 0.24% | +18.1% |
| Q4 2019 | $652,000 | +27.1% | 21,309 | 0.0% | 0.20% | +18.5% |
| Q3 2019 | $513,000 | -13.2% | 21,309 | -8.6% | 0.17% | -12.5% |
| Q2 2019 | $591,000 | – | 23,309 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |